COMMUNIQUÉS West-GlobeNewswire
-
Atsena Presents Positive Interim Six-Month Results from Part B of Phase 1/2/3 LIGHTHOUSE Trial Evaluating ATSN-201 in Patients with X-linked Retinoschisis
04/05/2026 -
Lifeward Announces New ReWalk® Data Presented at ASIA 2026 Conference Demonstrating a Comprehensive Longitudinal Safety Analysis for a Powered Exoskeleton
04/05/2026 -
LENZ Therapeutics to Report First Quarter 2026 Financial Results and Recent Corporate Highlights on May 11, 2026 and Attend Upcoming Investor Conference
04/05/2026 -
HealthLynked Launches New Consumer Platform and Multi-Site Digital Ecosystem to Redefine the Front Door to Healthcare
04/05/2026 -
Nanox Announces Distribution Agreement with NuvioDx to Support Deployment of Nanox.ARC Systems
04/05/2026 -
Bascom Palmer Eye Institute Presents Four Posters on Rose Bengal Photodynamic Antimicrobial Therapy at ARVO 2026, Advancing the Clinical Case for Provectus’s VisiRose Subsidiary and Rose Bengal Sodium in Infectious Keratitis
04/05/2026 -
Valitor Presents Preclinical Data Demonstrating Superior Durability with Six-month Treatment Protocol of VLTR-559 to Treat Wet AMD
04/05/2026 -
Candel Therapeutics to Host Investor Conference Call Following Presentation of Extended Data from Phase 3 Trial of Aglatimagene Besadenovec in Localized Prostate Cancer at the American Urological Association 2026 Annual Meeting
04/05/2026 -
Serefin Health Launches MyCareSteps Program to Support Care Coordination Across Grey Bruce
04/05/2026 -
Abeona Therapeutics® Announces Date of First Quarter Financial Results
04/05/2026 -
Dentsply Sirona Launches Smart View - Detect, World’s First FDA-Cleared AI-enabled diagnostic aid for detecting teeth with Periapical Radiolucencies in CBCTs
04/05/2026 -
Mapi Pharma Explores U.S. Aseptic Manufacturing Facility to Support Growing Demand for Aseptic and Long-Acting Generic and innovative Injectables
04/05/2026 -
NewGen Provides Update on Fiscal Year 2025 Results and Strategic Progress
04/05/2026 -
Fortress Biotech to Participate in the H.C. Wainwright 2nd Annual Royalty Company Virtual Conference
04/05/2026 -
Sienna Continues Platform Growth
04/05/2026 -
Bicara Therapeutics to Report First Quarter 2026 Financial Results and Business Updates on May 11, 2026, at 8:30 AM ET
04/05/2026 -
FibroBiologics Announces Release of CYWC628 Drug Product for Phase 1/2 Diabetic Foot Ulcer Clinical Trial
04/05/2026 -
Brainway Launches Personalized Anti-Procrastination App Grounded in CBT, Earns 6,000+ User Reviews
04/05/2026 -
Polyrizon Announces U.S. Patent Expansion for Its Intranasal Drug Delivery Platform
04/05/2026
Pages